Chitnis, Kshitij
Lu, Yizhou
Rhoads, Benjamin
Chakka, Leela Raghava Jaidev
Choudhury, Samrat
Maniruzzaman, Mohammed https://orcid.org/0000-0002-3373-5586
Article History
Received: 30 July 2025
Accepted: 22 October 2025
First Online: 4 November 2025
Declarations
:
: This study did not involve the use of any animal or human subjects.
: All authors have provided their consent for the publication of the manuscript in the journal.
: Both Leela Raghava Jaidev Chakka (L.C.) and Mohammed Maniruzzaman (M.M.) are co-inventors of related intellectual property (IP). M.M., an author of this manuscript, holds stock in, serves on a scientific advisory board for, or is a consultant for CoM3D Ltd. (Surrey, UK), DosePlus Therapeutics, Inc. (Princeton, NJ, USA), and Septum Solutions LLC (Houston, TX, USA). M.M and L.C. also hold stock in SmarGic Tech LLC (Oxford, MS, USA). The terms of this arrangement have been reviewed and approved by the University of Texas at Austin and the University of Mississippi (Ole Miss) in accordance with their policies on objectivity in research. The companies had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; and in the decision to publish the results.